161 related articles for article (PubMed ID: 35480111)
1. An Efficient Nomogram for Discriminating Intrahepatic Cholangiocarcinoma From Hepatocellular Carcinoma: A Retrospective Study.
Si YQ; Wang XQ; Pan CC; Wang Y; Lu ZM
Front Oncol; 2022; 12():833999. PubMed ID: 35480111
[TBL] [Abstract][Full Text] [Related]
2. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
[TBL] [Abstract][Full Text] [Related]
3. A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Wang M; Gao Y; Feng H; Warner E; An M; Jia J; Chen S; Fang M; Ji J; Gu X; Gao C
Cancer Med; 2018 Mar; 7(3):646-654. PubMed ID: 29473340
[TBL] [Abstract][Full Text] [Related]
4. Serum N-glycan fingerprint helps to discriminate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Huang C; Xu X; Wang M; Xiao X; Cheng C; Ji J; Fang M; Gao C
Electrophoresis; 2021 Jun; 42(11):1187-1195. PubMed ID: 33570803
[TBL] [Abstract][Full Text] [Related]
5. Nomogram based on Sonazoid contrast-enhanced ultrasound to differentiate intrahepatic cholangiocarcinoma and poorly differentiated hepatocellular carcinoma: a prospective multicenter study.
Wang S; Yao J; Li K; Yang H; Lu S; He G; Wu W; Cheng W; Jiang T; Ding H; Jing X; Yan Y; Liu F; Yu J; Han Z; Cheng Z; Tan S; Li X; Dou J; Li Y; Qi E; Zhang Y; Liang P; Yu X
Abdom Radiol (NY); 2023 Oct; 48(10):3101-3113. PubMed ID: 37436451
[TBL] [Abstract][Full Text] [Related]
6. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
Huang JY; Li JW; Ling WW; Li T; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Jul; 26(27):3938-3951. PubMed ID: 32774068
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and Prognostic Nomograms for Hepatocellular Carcinoma Based on PIVKA-II and Serum Biomarkers.
An S; Zhan X; Liu M; Li L; Wu J
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189543
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators.
Chen Y; Lu Q; Zhang W; Cao J; Dong Y; Wang W
Front Oncol; 2022; 12():757774. PubMed ID: 35242699
[TBL] [Abstract][Full Text] [Related]
9. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Zhang X; Huang WJ; Zhang ML; Wang W; Niu Y; Wang RT; Liu ZY
BMC Gastroenterol; 2022 Jun; 22(1):288. PubMed ID: 35668355
[TBL] [Abstract][Full Text] [Related]
10. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
[TBL] [Abstract][Full Text] [Related]
11. A nomogram to predict microvascular invasion in early hepatocellular carcinoma.
Li H; Li T; Hu J; Liu J
J Cancer Res Ther; 2021 Jul; 17(3):652-657. PubMed ID: 34269295
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
14. Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis.
Xing H; Zheng YJ; Han J; Zhang H; Li ZL; Lau WY; Shen F; Yang T
Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):487-495. PubMed ID: 30257796
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Serum GDF15, AFP, and PIVKA-II as Diagnostic Markers for HBV-Associated Hepatocellular Carcinoma.
Chen J; Tang D; Xu C; Niu Z; Li H; Li Y; Zhang P
Lab Med; 2021 Jul; 52(4):381-389. PubMed ID: 33159511
[TBL] [Abstract][Full Text] [Related]
16. A Nomogram Based on Preoperative Inflammatory Indices and ICG-R15 for Prediction of Liver Failure After Hepatectomy in HCC Patients.
Fang T; Long G; Wang D; Liu X; Xiao L; Mi X; Su W; Zhou L; Zhou L
Front Oncol; 2021; 11():667496. PubMed ID: 34277414
[TBL] [Abstract][Full Text] [Related]
17. Nomogram For Preoperative Prediction Of Microvascular Invasion Risk In Hepatocellular Carcinoma.
Deng G; Yao L; Zeng F; Xiao L; Wang Z
Cancer Manag Res; 2019; 11():9037-9045. PubMed ID: 31695495
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.
Wu J; Xiang Z; Bai L; He L; Tan L; Hu M; Ren Y
Cancer Biomark; 2018; 23(2):235-242. PubMed ID: 30103302
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
20. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
